Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

NCT01156779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: SR-exenatide

Sponsor

Dong-A Pharmaceutical Co., Ltd.